Evidence-based articles on medication tapering, clinical protocols, and the science of safe deprescribing.
The February 2026 JAMA/ASCP consensus statement formally recognizes structured psychotropic deprescribing as standard of care. Here's what it means for your practice.
Read more →SSRI discontinuation syndrome affects up to 56% of patients who stop abruptly. Learn the evidence-based approach to safe SSRI tapering using hyperbolic dose reductions.
Read more →The Maudsley Guidelines represent a paradigm shift in how we approach medication withdrawal. Here's what matters most for your practice.
Read more →Most taper protocols use linear reductions, but receptor occupancy follows a hyperbolic curve. Understanding this distinction changes how you deprescribe.
Read more →